Related references
Note: Only part of the references are listed.Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations
Jacob D. Soumerai et al.
LANCET HAEMATOLOGY (2019)
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study
Antonio Cuneo et al.
HAEMATOLOGICA (2018)
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study
Antonio Cuneo et al.
HAEMATOLOGICA (2018)
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia
Natali Pflug et al.
BLOOD (2014)
Share Paper
